JP2004534035A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004534035A5 JP2004534035A5 JP2002589475A JP2002589475A JP2004534035A5 JP 2004534035 A5 JP2004534035 A5 JP 2004534035A5 JP 2002589475 A JP2002589475 A JP 2002589475A JP 2002589475 A JP2002589475 A JP 2002589475A JP 2004534035 A5 JP2004534035 A5 JP 2004534035A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenyl
- trifluoromethyl
- acetic acid
- thio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 41
- 150000001875 compounds Chemical class 0.000 claims 20
- 125000003118 aryl group Chemical group 0.000 claims 8
- -1 perfluoro Chemical group 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- OGIHVIPVTSNHSP-UHFFFAOYSA-N 2-[4-[[2-(benzylsulfanylmethyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)CSCC=2C=CC=CC=2)=C1 OGIHVIPVTSNHSP-UHFFFAOYSA-N 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- GRRWANPLQMUWDL-UHFFFAOYSA-N 2-[4-[[5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1 GRRWANPLQMUWDL-UHFFFAOYSA-N 0.000 claims 3
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- SFNNLGOPNQUXCV-UHFFFAOYSA-N 2-[2-ethyl-4-[[2-methyl-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(CC)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)C)=C1 SFNNLGOPNQUXCV-UHFFFAOYSA-N 0.000 claims 2
- IFGWJUVVQJCSBR-UHFFFAOYSA-N 2-[2-methyl-4-[2-[2-methyl-5-[4-(trifluoromethyl)phenyl]furan-3-yl]ethyl]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CCC1=CC=C(OCC(O)=O)C(C)=C1 IFGWJUVVQJCSBR-UHFFFAOYSA-N 0.000 claims 2
- APSHKIJUEPDIOL-UHFFFAOYSA-N 2-[2-methyl-4-[2-[3-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]ethyl]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CCC1=CC=C(OCC(O)=O)C(C)=C1 APSHKIJUEPDIOL-UHFFFAOYSA-N 0.000 claims 2
- GAMPIJLBSSQQJO-UHFFFAOYSA-N 2-[2-methyl-4-[2-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]phenoxy]acetic acid Chemical compound CC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CCC1=CC=C(OCC(O)=O)C(C)=C1 GAMPIJLBSSQQJO-UHFFFAOYSA-N 0.000 claims 2
- BXAAPBCAAXFNBT-UHFFFAOYSA-N 2-[2-methyl-4-[[2-(3-methylbutyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC(C)CCC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 BXAAPBCAAXFNBT-UHFFFAOYSA-N 0.000 claims 2
- PLPKWTIJWDCGJS-UHFFFAOYSA-N 2-[2-methyl-4-[[2-(propan-2-ylsulfanylmethyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC(C)SCC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 PLPKWTIJWDCGJS-UHFFFAOYSA-N 0.000 claims 2
- ACFOOAHSONTJOH-UHFFFAOYSA-N 2-[2-methyl-4-[[2-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)C(F)(F)F)=C1 ACFOOAHSONTJOH-UHFFFAOYSA-N 0.000 claims 2
- LXNJDHJMSCSYMK-UHFFFAOYSA-N 2-[2-methyl-4-[[2-[(n-methylanilino)methyl]-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C=1C=CC=CC=1N(C)CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 LXNJDHJMSCSYMK-UHFFFAOYSA-N 0.000 claims 2
- YQGCQTMMVIIVLC-UHFFFAOYSA-N 2-[2-methyl-4-[[2-methyl-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 YQGCQTMMVIIVLC-UHFFFAOYSA-N 0.000 claims 2
- NJAUWCZVYRTXBK-UHFFFAOYSA-N 2-[2-methyl-4-[[2-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-3-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1SC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1COC1=CC=C(OCC(O)=O)C(C)=C1 NJAUWCZVYRTXBK-UHFFFAOYSA-N 0.000 claims 2
- ITRQPZTWQRRMLO-UHFFFAOYSA-N 2-[2-methyl-4-[[2-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC=1SC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 ITRQPZTWQRRMLO-UHFFFAOYSA-N 0.000 claims 2
- RWIGMUATWNDKOG-UHFFFAOYSA-N 2-[2-methyl-4-[[3-(phenoxymethyl)-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(C=C(S2)C=2C=CC(=CC=2)C(F)(F)F)COC=2C=CC=CC=2)=C1 RWIGMUATWNDKOG-UHFFFAOYSA-N 0.000 claims 2
- QZMBSSNIFPSIFA-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-4-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound S1C=C(C=2C=CC(=CC=2)C(F)(F)F)C(C)=C1CSC1=CC=C(OCC(O)=O)C(C)=C1 QZMBSSNIFPSIFA-UHFFFAOYSA-N 0.000 claims 2
- RYDLVQHROFTVOM-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-5-[4-(trifluoromethoxy)phenyl]thiophen-2-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(OC(F)(F)F)=CC=2)SC=1COC1=CC=C(OCC(O)=O)C(C)=C1 RYDLVQHROFTVOM-UHFFFAOYSA-N 0.000 claims 2
- QWZDPYZVCBHSEZ-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-5-[4-(trifluoromethyl)phenyl]furan-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)OC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 QWZDPYZVCBHSEZ-UHFFFAOYSA-N 0.000 claims 2
- YOCZJLKEOZCIGA-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1COC1=CC=C(OCC(O)=O)C(C)=C1 YOCZJLKEOZCIGA-UHFFFAOYSA-N 0.000 claims 2
- RCYQDTIQCZUMKJ-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 RCYQDTIQCZUMKJ-UHFFFAOYSA-N 0.000 claims 2
- ZOFQTJMODLMZPP-UHFFFAOYSA-N 2-[4-[2-[5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-yl]ethyl]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(CCC2=C(OC(=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1 ZOFQTJMODLMZPP-UHFFFAOYSA-N 0.000 claims 2
- MTRUSCUYORMMOS-UHFFFAOYSA-N 2-[4-[[2-methyl-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]-2-propan-2-ylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C(C)C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)C)=C1 MTRUSCUYORMMOS-UHFFFAOYSA-N 0.000 claims 2
- TVIYUKWTXNGZIY-UHFFFAOYSA-N 2-[4-[[3-ethyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound CCC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 TVIYUKWTXNGZIY-UHFFFAOYSA-N 0.000 claims 2
- PUWXDYPTEZFQDT-UHFFFAOYSA-N 2-[4-[[5-(4-chlorophenyl)-2-methylfuran-3-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(Cl)=CC=2)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 PUWXDYPTEZFQDT-UHFFFAOYSA-N 0.000 claims 2
- NYKCZJCAVYIWAV-UHFFFAOYSA-N 3-[2-methyl-4-[2-[3-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]ethyl]phenyl]propanoic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CCC1=CC=C(CCC(O)=O)C(C)=C1 NYKCZJCAVYIWAV-UHFFFAOYSA-N 0.000 claims 2
- ZYNQSBLIFRMDLD-UHFFFAOYSA-N 3-[2-methyl-4-[[3-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methoxy]phenyl]propanoic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1COC1=CC=C(CCC(O)=O)C(C)=C1 ZYNQSBLIFRMDLD-UHFFFAOYSA-N 0.000 claims 2
- JSNSIMSPRLOPEO-UHFFFAOYSA-N 3-[4-[[3-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methoxy]phenyl]propanoic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1COC1=CC=C(CCC(O)=O)C=C1 JSNSIMSPRLOPEO-UHFFFAOYSA-N 0.000 claims 2
- 208000000103 Anorexia Nervosa Diseases 0.000 claims 2
- 101000741788 Homo sapiens Peroxisome proliferator-activated receptor alpha Proteins 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 claims 2
- 125000005275 alkylenearyl group Chemical group 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- BBLUXMGQSDRGJA-UHFFFAOYSA-N 2-[2-methyl-4-[1-[3-methyl-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]ethoxy]phenoxy]acetic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=CC(C)=C1C(C)OC1=CC=C(OCC(O)=O)C(C)=C1 BBLUXMGQSDRGJA-UHFFFAOYSA-N 0.000 claims 1
- CBEIZYSKUHRBSX-UHFFFAOYSA-N 2-[2-methyl-4-[1-[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]ethoxy]phenoxy]acetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(C)OC1=CC=C(OCC(O)=O)C(C)=C1 CBEIZYSKUHRBSX-UHFFFAOYSA-N 0.000 claims 1
- HLCJTTRMBMZTSS-UHFFFAOYSA-N 2-[2-methyl-4-[1-[5-[4-(trifluoromethyl)phenyl]thiophen-3-yl]ethoxy]phenoxy]acetic acid Chemical compound C=1SC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1C(C)OC1=CC=C(OCC(O)=O)C(C)=C1 HLCJTTRMBMZTSS-UHFFFAOYSA-N 0.000 claims 1
- MYKMFVMSLQQNGT-UHFFFAOYSA-N 2-[2-methyl-4-[[2-(2-methylpropyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC(C)CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 MYKMFVMSLQQNGT-UHFFFAOYSA-N 0.000 claims 1
- UHWSZKUHVZTHMD-UHFFFAOYSA-N 2-[2-methyl-4-[[2-(2-pyridin-4-ylethyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid;hydrochloride Chemical compound Cl.C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)CCC=2C=CN=CC=2)=C1 UHWSZKUHVZTHMD-UHFFFAOYSA-N 0.000 claims 1
- AIRWCGGTUHPHNS-UHFFFAOYSA-N 2-[2-methyl-4-[[2-(phenoxymethyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)COC=2C=CC=CC=2)=C1 AIRWCGGTUHPHNS-UHFFFAOYSA-N 0.000 claims 1
- YJFZVLMAJHJFJC-UHFFFAOYSA-N 2-[2-methyl-4-[[2-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methoxy]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(OCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)C(F)(F)F)=C1 YJFZVLMAJHJFJC-UHFFFAOYSA-N 0.000 claims 1
- SDXYXAXTXVTKBP-UHFFFAOYSA-N 2-[2-methyl-4-[[2-[2-(4-methylphenyl)ethyl]-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=CC(C)=CC=C1CCC1=C(CSC=2C=C(C)C(OCC(O)=O)=CC=2)C=C(C=2C=CC(=CC=2)C(F)(F)F)O1 SDXYXAXTXVTKBP-UHFFFAOYSA-N 0.000 claims 1
- BRTCHXMHYSMHJJ-UHFFFAOYSA-N 2-[2-methyl-4-[[2-[[methyl(2-phenylethyl)amino]methyl]-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid;hydrochloride Chemical compound Cl.O1C(C=2C=CC(=CC=2)C(F)(F)F)=CC(CSC=2C=C(C)C(OCC(O)=O)=CC=2)=C1CN(C)CCC1=CC=CC=C1 BRTCHXMHYSMHJJ-UHFFFAOYSA-N 0.000 claims 1
- GIVRDNCABIOBRR-UHFFFAOYSA-N 2-[2-methyl-4-[[2-methyl-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1COC1=CC=C(OCC(O)=O)C(C)=C1 GIVRDNCABIOBRR-UHFFFAOYSA-N 0.000 claims 1
- RBQLTRZGQRMWFQ-UHFFFAOYSA-N 2-[2-methyl-4-[[3-(propan-2-ylsulfanylmethyl)-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methoxy]phenoxy]acetic acid Chemical compound CC(C)SCC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1COC1=CC=C(OCC(O)=O)C(C)=C1 RBQLTRZGQRMWFQ-UHFFFAOYSA-N 0.000 claims 1
- LCLKBXKOLVIZQR-UHFFFAOYSA-N 2-[2-methyl-4-[[3-(propan-2-ylsulfanylmethyl)-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC(C)SCC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 LCLKBXKOLVIZQR-UHFFFAOYSA-N 0.000 claims 1
- WTFZAJWHDSOBLE-UHFFFAOYSA-N 2-[2-methyl-4-[[3-[(n-methylanilino)methyl]-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C=1C=CC=CC=1N(C)CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 WTFZAJWHDSOBLE-UHFFFAOYSA-N 0.000 claims 1
- AZHPTSALPMQRGW-UHFFFAOYSA-N 2-[2-methyl-4-[[3-[[4-(trifluoromethyl)phenoxy]methyl]-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(C=C(S2)C=2C=CC(=CC=2)C(F)(F)F)COC=2C=CC(=CC=2)C(F)(F)F)=C1 AZHPTSALPMQRGW-UHFFFAOYSA-N 0.000 claims 1
- RZAFHMYSLNFMNQ-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-5-[4-(1,1,2,2-tetrafluoroethoxy)phenyl]thiophen-2-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(OC(F)(F)C(F)F)=CC=2)SC=1COC1=CC=C(OCC(O)=O)C(C)=C1 RZAFHMYSLNFMNQ-UHFFFAOYSA-N 0.000 claims 1
- UPWRVBXHFNSFQT-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-5-[4-(trifluoromethoxy)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(OC(F)(F)F)=CC=2)SC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 UPWRVBXHFNSFQT-UHFFFAOYSA-N 0.000 claims 1
- UUQKPRXFMLMBMG-UHFFFAOYSA-N 2-[2-methyl-4-[[3-methyl-5-[4-(trifluoromethyl)phenyl]furan-2-yl]methoxy]phenoxy]acetic acid Chemical compound CC=1C=C(C=2C=CC(=CC=2)C(F)(F)F)OC=1COC1=CC=C(OCC(O)=O)C(C)=C1 UUQKPRXFMLMBMG-UHFFFAOYSA-N 0.000 claims 1
- MCAMNELDXNLQFK-UHFFFAOYSA-N 2-[2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]furan-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC=2OC(=CC=2)C=2C=CC(=CC=2)C(F)(F)F)=C1 MCAMNELDXNLQFK-UHFFFAOYSA-N 0.000 claims 1
- YMFYVQVRPWQAIC-UHFFFAOYSA-N 2-[2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC=2C=C(OC=2)C=2C=CC(=CC=2)C(F)(F)F)=C1 YMFYVQVRPWQAIC-UHFFFAOYSA-N 0.000 claims 1
- XEUGLMGFMXQQRN-UHFFFAOYSA-N 2-[2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC=2SC(=CC=2)C=2C=CC(=CC=2)C(F)(F)F)=C1 XEUGLMGFMXQQRN-UHFFFAOYSA-N 0.000 claims 1
- IYMWINVCTXDNAV-UHFFFAOYSA-N 2-[2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]thiophen-3-yl]methylsulfanyl]phenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC=2C=C(SC=2)C=2C=CC(=CC=2)C(F)(F)F)=C1 IYMWINVCTXDNAV-UHFFFAOYSA-N 0.000 claims 1
- PHIRDEHXYOMRQH-UHFFFAOYSA-N 2-[4-[[2-(furan-2-ylmethylsulfanylmethyl)-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)CSCC=2OC=CC=2)=C1 PHIRDEHXYOMRQH-UHFFFAOYSA-N 0.000 claims 1
- ODFQQKIPPLXPMJ-UHFFFAOYSA-N 2-[4-[[2-[(2,4-difluorophenyl)sulfanylmethyl]-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)CSC=2C(=CC(F)=CC=2)F)=C1 ODFQQKIPPLXPMJ-UHFFFAOYSA-N 0.000 claims 1
- SXOWQVCVAJUPMS-UHFFFAOYSA-N 2-[4-[[2-[(3,5-dimethylphenyl)sulfanylmethyl]-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound CC1=CC(C)=CC(SCC2=C(C=C(O2)C=2C=CC(=CC=2)C(F)(F)F)CSC=2C=C(C)C(OCC(O)=O)=CC=2)=C1 SXOWQVCVAJUPMS-UHFFFAOYSA-N 0.000 claims 1
- IDTGXFJFUKLFEN-UHFFFAOYSA-N 2-[4-[[2-[(4-tert-butylphenyl)sulfanylmethyl]-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(OC(=C2)C=2C=CC(=CC=2)C(F)(F)F)CSC=2C=CC(=CC=2)C(C)(C)C)=C1 IDTGXFJFUKLFEN-UHFFFAOYSA-N 0.000 claims 1
- YFSYOPQVNBHVBU-UHFFFAOYSA-N 2-[4-[[2-methyl-5-[4-(trifluoromethyl)phenyl]furan-3-yl]methylsulfanyl]-2-(trifluoromethyl)phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C(F)(F)F)=C1 YFSYOPQVNBHVBU-UHFFFAOYSA-N 0.000 claims 1
- QOYYFIVYYRAKLC-UHFFFAOYSA-N 2-[4-[[3-(benzylsulfanylmethyl)-5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(SCC2=C(C=C(S2)C=2C=CC(=CC=2)C(F)(F)F)CSCC=2C=CC=CC=2)=C1 QOYYFIVYYRAKLC-UHFFFAOYSA-N 0.000 claims 1
- CBSFAEQCEQSAHC-UHFFFAOYSA-N 2-[4-[[5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-yl]methoxy]-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC(OCC2=C(OC(=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1 CBSFAEQCEQSAHC-UHFFFAOYSA-N 0.000 claims 1
- SZIQXEQVPOYRNY-UHFFFAOYSA-N 2-[4-[[5-(4-chlorophenyl)-2-methylfuran-3-yl]methoxy]-2-methylphenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(Cl)=CC=2)=CC=1COC1=CC=C(OCC(O)=O)C(C)=C1 SZIQXEQVPOYRNY-UHFFFAOYSA-N 0.000 claims 1
- UYDAXIJQZDVGMK-UHFFFAOYSA-N 2-[4-[[5-(4-chlorophenyl)-2-methylfuran-3-yl]methylsulfanyl]-2-(trifluoromethyl)phenoxy]acetic acid Chemical compound CC=1OC(C=2C=CC(Cl)=CC=2)=CC=1CSC1=CC=C(OCC(O)=O)C(C(F)(F)F)=C1 UYDAXIJQZDVGMK-UHFFFAOYSA-N 0.000 claims 1
- XHPVYJHZQFIHLT-UHFFFAOYSA-N 2-[4-[[5-[2,3-difluoro-4-(trifluoromethyl)phenyl]-3-methylthiophen-2-yl]methoxy]-2-methylphenoxy]acetic acid Chemical compound CC=1C=C(C=2C(=C(F)C(=CC=2)C(F)(F)F)F)SC=1COC1=CC=C(OCC(O)=O)C(C)=C1 XHPVYJHZQFIHLT-UHFFFAOYSA-N 0.000 claims 1
- OIILLEZAFONCDR-UHFFFAOYSA-N 2-[4-[[5-[2,5-difluoro-4-(trifluoromethyl)phenyl]-3-methylthiophen-2-yl]methoxy]-2-methylphenoxy]acetic acid Chemical compound CC=1C=C(C=2C(=CC(=C(F)C=2)C(F)(F)F)F)SC=1COC1=CC=C(OCC(O)=O)C(C)=C1 OIILLEZAFONCDR-UHFFFAOYSA-N 0.000 claims 1
- NCBKIYWMBUIWNA-UHFFFAOYSA-N 2-[4-[[5-[2-fluoro-4-(trifluoromethyl)phenyl]-3-methylthiophen-2-yl]methoxy]-2-methylphenoxy]acetic acid Chemical compound CC=1C=C(C=2C(=CC(=CC=2)C(F)(F)F)F)SC=1COC1=CC=C(OCC(O)=O)C(C)=C1 NCBKIYWMBUIWNA-UHFFFAOYSA-N 0.000 claims 1
- XHFHPHCRPUUCBS-UHFFFAOYSA-N 2-methyl-2-[2-methyl-4-[phenyl-[5-[4-(trifluoromethyl)phenyl]thiophen-3-yl]methoxy]phenoxy]propanoic acid Chemical compound C1=C(OC(C)(C)C(O)=O)C(C)=CC(OC(C=2C=C(SC=2)C=2C=CC(=CC=2)C(F)(F)F)C=2C=CC=CC=2)=C1 XHFHPHCRPUUCBS-UHFFFAOYSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- FFMJLHDVACASSI-UHFFFAOYSA-N 3-[2-methyl-4-[2-[2-methyl-5-[4-(trifluoromethyl)phenyl]furan-3-yl]ethyl]phenyl]propanoic acid Chemical compound CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CCC1=CC=C(CCC(O)=O)C(C)=C1 FFMJLHDVACASSI-UHFFFAOYSA-N 0.000 claims 1
- HFRYZGKPKOQJPS-UHFFFAOYSA-N 3-[4-[[5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-yl]methoxy]-2-methylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=CC(OCC2=C(OC(=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1 HFRYZGKPKOQJPS-UHFFFAOYSA-N 0.000 claims 1
- NRGRJXGBBXXZOU-UHFFFAOYSA-N 3-[4-[[5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-yl]methoxy]phenyl]propanoic acid Chemical compound C1=CC(CCC(=O)O)=CC=C1OCC1=C(C(F)(F)F)OC(C=2C=CC(Cl)=CC=2)=C1 NRGRJXGBBXXZOU-UHFFFAOYSA-N 0.000 claims 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- SPBGXUAHMQXDRP-UHFFFAOYSA-N C=1C=CN=CC=1CN(C)CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 Chemical compound C=1C=CN=CC=1CN(C)CC=1OC(C=2C=CC(=CC=2)C(F)(F)F)=CC=1CSC1=CC=C(OCC(O)=O)C(C)=C1 SPBGXUAHMQXDRP-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 206010020710 Hyperphagia Diseases 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 235000020830 overeating Nutrition 0.000 claims 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0111523.7A GB0111523D0 (en) | 2001-05-11 | 2001-05-11 | Chemical compounds |
| PCT/GB2002/002152 WO2002092590A1 (en) | 2001-05-11 | 2002-05-09 | Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004534035A JP2004534035A (ja) | 2004-11-11 |
| JP2004534035A5 true JP2004534035A5 (OSRAM) | 2005-12-22 |
Family
ID=9914442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002589475A Pending JP2004534035A (ja) | 2001-05-11 | 2002-05-09 | ヒト・ペルオキシソーム増殖因子活性化受容体を活性化するフランおよびチオフェン誘導体 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7091237B2 (OSRAM) |
| EP (1) | EP1392674B1 (OSRAM) |
| JP (1) | JP2004534035A (OSRAM) |
| KR (1) | KR20040023600A (OSRAM) |
| CN (1) | CN1507442A (OSRAM) |
| AT (1) | ATE301649T1 (OSRAM) |
| BR (1) | BR0209468A (OSRAM) |
| CA (1) | CA2446797A1 (OSRAM) |
| CO (1) | CO5540343A2 (OSRAM) |
| CZ (1) | CZ20033064A3 (OSRAM) |
| DE (1) | DE60205481T2 (OSRAM) |
| ES (1) | ES2247322T3 (OSRAM) |
| GB (1) | GB0111523D0 (OSRAM) |
| HU (1) | HUP0304051A3 (OSRAM) |
| IL (1) | IL158332A0 (OSRAM) |
| MX (1) | MXPA03010285A (OSRAM) |
| NO (1) | NO20034986L (OSRAM) |
| PL (1) | PL367478A1 (OSRAM) |
| WO (1) | WO2002092590A1 (OSRAM) |
| ZA (1) | ZA200308352B (OSRAM) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
| GB0113232D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical process |
| MXPA04001258A (es) | 2001-08-10 | 2005-06-06 | Nippon Chemiphar Co | Activador para el receptor d que responde al proliferador de peroxisoma. |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
| US20030207924A1 (en) * | 2002-03-07 | 2003-11-06 | Xue-Min Cheng | Compounds that modulate PPAR activity and methods of preparation |
| US6875780B2 (en) * | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
| US7553867B2 (en) | 2002-09-06 | 2009-06-30 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
| JP2005035966A (ja) * | 2002-09-06 | 2005-02-10 | Takeda Chem Ind Ltd | フランまたはチオフェン誘導体およびその医薬用途 |
| US7960369B2 (en) * | 2002-11-08 | 2011-06-14 | Takeda Pharmaceutical Company Limited | Receptor function regulator |
| AU2003296402A1 (en) * | 2003-01-06 | 2004-08-10 | Eli Lilly And Company | Thiophene derivative ppar modulators |
| US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| EP1493739A1 (fr) * | 2003-07-03 | 2005-01-05 | Warner-Lambert Company LLC | Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
| US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| KR20080042188A (ko) | 2003-11-05 | 2008-05-14 | 에프. 호프만-라 로슈 아게 | Ｐｐａｒ 작용제로서 페닐 유도체 |
| WO2005063729A1 (en) | 2003-12-25 | 2005-07-14 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| EP1698624B1 (en) | 2003-12-26 | 2012-06-27 | Takeda Pharmaceutical Company Limited | Phenylpropanoic acid derivatives |
| GB0403148D0 (en) * | 2004-02-12 | 2004-03-17 | Smithkline Beecham Corp | Chemical compounds |
| DE602004004631D1 (de) | 2004-04-01 | 2007-03-22 | Sanofi Aventis Deutschland | Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika |
| EP1854784A1 (en) * | 2005-02-28 | 2007-11-14 | Nippon Chemiphar Co., Ltd. | Activator for peroxisome proliferator activating receptor |
| WO2006121223A1 (en) * | 2005-05-07 | 2006-11-16 | Heon Joong Kang | Process for preparing ligands of ppardelta and the intermediate compounds for preparing the same |
| KR20080014075A (ko) * | 2005-05-25 | 2008-02-13 | 닛뽕 케미파 가부시키가이샤 | 페록시좀 증식제 활성화 수용체의 활성화제 |
| EP1931337B1 (en) | 2005-09-29 | 2013-10-23 | Sanofi | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| AU2006299092A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl-(1,2,4)-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| WO2007127502A2 (en) * | 2006-01-10 | 2007-11-08 | Smithkline Beecham Corporation | Polymorphic form of { 2-methyl-4- [ 4-methyl-2- ( 4-triflu0r0methylphenyl) thiazol -5- ylmethylthiol phenoxy }-acetic acid |
| RU2435764C2 (ru) | 2006-04-18 | 2011-12-10 | Ниппон Кемифар Ко., Лтд. | АГЕНТ, АКТИВИРУЮЩИЙ РЕЦЕПТОР, АКТИВИРУЕМЫЙ ПРОЛИФЕРАТОРАМИ ПЕРОКСИСОМ δ |
| KR101467590B1 (ko) * | 2006-08-22 | 2014-12-01 | 랜박시 래보러터리스 리미티드 | 매트릭스 메탈로프로테나제 저해제 |
| FR2910894A1 (fr) * | 2006-12-29 | 2008-07-04 | Genfit Sa | Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation. |
| CA2672420A1 (en) | 2006-12-29 | 2008-07-10 | The Salk Institute For Biological Studies | Methods for enhancing exercise performance |
| EA200970793A1 (ru) * | 2007-02-23 | 2010-02-26 | Эли Лилли Энд Компани | Модуляторы рецепторов, активируемых пролифераторами пероксисом |
| GB2460784A (en) * | 2007-03-07 | 2009-12-16 | Dong A Pharmtech Co Ltd | Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators,method of the same,and pharmaceutical composition |
| DE102008007400A1 (de) * | 2008-02-04 | 2009-08-06 | Bayer Healthcare Ag | Substituierte Furane und ihre Verwendung |
| AU2009236877B2 (en) | 2008-04-15 | 2014-01-23 | Nippon Chemiphar Co., Ltd. | Activator for peroxisome proliferator-activated receptor |
| CN101643451B (zh) * | 2008-08-07 | 2013-03-06 | 浙江海正药业股份有限公司 | 过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法 |
| WO2012030165A2 (ko) | 2010-08-31 | 2012-03-08 | 서울대학교산학협력단 | P P A R δ 활성물질의 태자재프로그래밍용도 |
| US10118922B2 (en) * | 2013-03-14 | 2018-11-06 | Janssen Pharmaceutica Nv | GPR120 agonists for the treatment of type II diabetes |
| CN105209450B (zh) * | 2013-03-14 | 2017-10-20 | 美国陶氏益农公司 | 具有一定农药效用的分子和中间体、组合物及其相关方法 |
| US11634387B2 (en) | 2019-09-26 | 2023-04-25 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
| WO2022189856A1 (en) * | 2021-03-08 | 2022-09-15 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| RU2267484C2 (ru) | 1999-04-28 | 2006-01-10 | Авентис Фарма Дойчланд Гмбх | Производные диариловой кислоты и фармацевтическая композиция на их основе |
-
2001
- 2001-05-11 GB GBGB0111523.7A patent/GB0111523D0/en not_active Ceased
-
2002
- 2002-05-09 KR KR10-2003-7014660A patent/KR20040023600A/ko not_active Withdrawn
- 2002-05-09 CZ CZ20033064A patent/CZ20033064A3/cs unknown
- 2002-05-09 WO PCT/GB2002/002152 patent/WO2002092590A1/en not_active Ceased
- 2002-05-09 CN CNA028096940A patent/CN1507442A/zh active Pending
- 2002-05-09 PL PL02367478A patent/PL367478A1/xx not_active Application Discontinuation
- 2002-05-09 AT AT02722506T patent/ATE301649T1/de not_active IP Right Cessation
- 2002-05-09 HU HU0304051A patent/HUP0304051A3/hu unknown
- 2002-05-09 MX MXPA03010285A patent/MXPA03010285A/es unknown
- 2002-05-09 IL IL15833202A patent/IL158332A0/xx unknown
- 2002-05-09 DE DE60205481T patent/DE60205481T2/de not_active Expired - Fee Related
- 2002-05-09 CA CA002446797A patent/CA2446797A1/en not_active Abandoned
- 2002-05-09 BR BR0209468-1A patent/BR0209468A/pt not_active IP Right Cessation
- 2002-05-09 US US10/476,194 patent/US7091237B2/en not_active Expired - Fee Related
- 2002-05-09 JP JP2002589475A patent/JP2004534035A/ja active Pending
- 2002-05-09 ES ES02722506T patent/ES2247322T3/es not_active Expired - Lifetime
- 2002-05-09 EP EP02722506A patent/EP1392674B1/en not_active Expired - Lifetime
-
2003
- 2003-10-27 ZA ZA200308352A patent/ZA200308352B/en unknown
- 2003-11-10 NO NO20034986A patent/NO20034986L/no not_active Application Discontinuation
- 2003-11-10 CO CO03099078A patent/CO5540343A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004534035A5 (OSRAM) | ||
| KR101179087B1 (ko) | 인간 단백질 티로신 포스파타아제 억제제 및 이용 방법 | |
| JP2006077019A5 (OSRAM) | ||
| RU2461551C2 (ru) | Азолкарбоксамидное соединение или его фармацевтически приемлемая соль | |
| ZA200308352B (en) | Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors. | |
| RU2379299C2 (ru) | Производные 5-(бенз-(z)-илиден)тиазолидин-4-она и их применение в качестве иммуносупрессорных агентов | |
| JP2004517080A5 (OSRAM) | ||
| JP2004520377A5 (OSRAM) | ||
| RU2011134631A (ru) | Вызывающие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний | |
| JP2004518702A5 (OSRAM) | ||
| JP2010519181A5 (OSRAM) | ||
| JP2005529077A5 (OSRAM) | ||
| RU2012116505A (ru) | Замещенные соединения амида | |
| NZ601794A (en) | Di - substituted pyridine derivatives as anticancers | |
| JP2013530240A5 (OSRAM) | ||
| RU2006123559A (ru) | Биарилсульфонамиды в качестве ммр-ингибиторов | |
| JP2008500284A5 (OSRAM) | ||
| JP2006516251A5 (OSRAM) | ||
| JP2004507501A5 (OSRAM) | ||
| RU2004104951A (ru) | Замещенные пиперазиновые соединения и их применение в качестве ингибиторов окисления жирных кислот | |
| JP2005526732A5 (OSRAM) | ||
| JP2004537554A5 (OSRAM) | ||
| JP2004517100A5 (OSRAM) | ||
| RU2004129285A (ru) | Производные тиазола в качестве антагонистов рецептора npy | |
| JP2018537419A5 (OSRAM) |